C-Jun N-terminal kinase signalling pathway in response to cisplatin
about
Overexpression of c-Jun contributes to sorafenib resistance in human hepatoma cell lines.Gankyrin as a potential therapeutic target for cancer.Cisplatin induces the release of extracellular vesicles from ovarian cancer cells that can induce invasiveness and drug resistance in bystander cells.JNK-signaling: A multiplexing hub in programmed cell death.p53 and metabolism: from mechanism to therapeutics.
P2860
C-Jun N-terminal kinase signalling pathway in response to cisplatin
description
2016 nî lūn-bûn
@nan
2016 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
C-Jun N-terminal kinase signalling pathway in response to cisplatin
@ast
C-Jun N-terminal kinase signalling pathway in response to cisplatin
@en
C-Jun N-terminal kinase signalling pathway in response to cisplatin
@nl
type
label
C-Jun N-terminal kinase signalling pathway in response to cisplatin
@ast
C-Jun N-terminal kinase signalling pathway in response to cisplatin
@en
C-Jun N-terminal kinase signalling pathway in response to cisplatin
@nl
prefLabel
C-Jun N-terminal kinase signalling pathway in response to cisplatin
@ast
C-Jun N-terminal kinase signalling pathway in response to cisplatin
@en
C-Jun N-terminal kinase signalling pathway in response to cisplatin
@nl
P2093
P2860
P921
P3181
P356
P1476
C-Jun N-terminal kinase signalling pathway in response to cisplatin
@en
P2093
GuangYu An
Macus Tien Kuo
P2860
P3181
P356
10.1111/JCMM.12908
P577
2016-07-04T00:00:00Z
2016-11-01T00:00:00Z